AlphAIAlphAI — Financial news for AI agents
SEC EDGARAUG 62 min read$CL

Wallace Noel R. sold $29.7M of CL

Wallace Noel R. (Chairman, President & CEO) sold 322,042 shares of COLGATE PALMOLIVE CO (CL) at an average of $92.22 ($91.92–$92.52, $29.70M total) across 2 trades over 2026-08-04 to 2026-08-05.

Original reporting
SEC EDGAR · Wallace Noel R.
Published Aug 6, 2026, 4:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 7, 2026, 7:42 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
$CL
Neutral
medium confidence
Mentioned
$CL
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CLNeutralLow
01

Why it matters

The disclosure updates the record of insider ownership and may influence short-term sentiment, but it does not provide new information about earnings, guidance, or business performance.

02

Market read

Traders may monitor CL for sentiment effects from insider selling, but the filing alone is unlikely to drive a durable repricing.

03

What to watch

No 10b5-1 plan details are provided in the text, and insider sales often have non-informational motives; traders should avoid over-weighting without corroborating fundamentals or guidance changes.

Relevance 7/10Novelty 5/10Timing: Form 4 filed 2026-08-06, covering sales on 2026-08-04 to 2026-08-05.

Background

The article is a SEC Form 4 insider transaction disclosure for Colgate-Palmolive (CL) by its Chairman, President and CEO.

Company-level read

Ticker impact

$CLNeutralMedium confidence
Context

Colgate-Palmolive CEO Wallace Noel R. sold 322,042 shares in open-market transactions totaling about $29.7M, per Form 4 filed Aug. 6.

Expected impact

Low near-term impact; any move is likely sentiment-driven and should fade unless accompanied by other news.

Evidence & confidence

The filing is a routine Form 4 open-market sale with no 10b5-1 plan disclosed and no accompanying operational or guidance change in the text.

Market effects

Sector

Minimal. Large-cap consumer staples insider sales are typically not sector-moving without additional company-specific catalysts.

Regional

None indicated.

Global

None indicated.

Counterpoint

What could challenge this read

The sale could be planned liquidity management rather than a bearish signal, especially given the multi-day execution window.

Key entities

  • issuer
    Colgate-Palmolive Co

    Subject of the Form 4 insider sale disclosure.

  • insider
    Wallace Noel R.

    Chairman, President and CEO who sold 322,042 shares for about $29.7M.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

CL insider trading history →

Related articles

OCT 9
High

Here's why Colgate-Palmolive shares jumped over 7% on Friday

Colgate-Palmolive (India) shares rose 8% after the GST Council recommended expanding input tax credit eligibility. The changes aim to reduce taxes and ease working-capital pressures. The company also benefited from a GST rate cut on oral-care products last year. Analysts estimate cost impacts from the inverted duty structure. The company reported strong revenue growth in Q1 FY27 and outlined growth strategies at an investor day.

cnbctv18.com2 min
SEP 28
$CLMedAI 8/10

Colgate-Palmolive (CL) is Making Room for Its Stronger Growth Engines. Will it Pay Off?

Colgate-Palmolive (CL) is considering selling mass-market personal care brands, including Softsoap and Speed Stick, for over $1 billion. The company aims to streamline its portfolio, focusing on higher-margin categories like Hill’s Pet Nutrition and international markets. Q2 2026 net sales rose 4.9% to $5.36 billion, with operating cash flow at $1.74 billion. Proceeds could reduce debt and optimize capital structure, but divestments may impact short-term revenue and earnings predictability.

insidermonkey.com2 min
SEP 21
$CLMed

Piper Sandler cuts Colgate-Palmolive stock price target on cost pressures

Piper Sandler reduced its price target for Colgate-Palmolive (CL) to $95 from $98, citing cost pressures from elevated oil prices and inventory headwinds. The firm maintained an Overweight rating and a 2026 EPS estimate of $3.85, but lowered its 2027 EPS estimate to $4.12 from $4.23. CL trades at $87.47 with a P/E ratio of 34.6 and a gross profit margin of 60%. Other analysts have maintained positive outlooks, with RBC and UBS setting higher price targets.

investing.com2 min
SEP 18
$CLMedAI 8/10

Colgate-Palmolive Explores Sale Of Softsoap, Irish Spring, Speed Stick Brands: Report

Colgate-Palmolive (CL) is exploring the sale of brands like Softsoap, Irish Spring, and Speed Stick, potentially fetching over $1 billion. The company is working with Goldman Sachs (GS) on the divestiture. Personal care accounted for 17% of CL's 2025 net sales, which totaled $20.38 billion. The move is part of a broader productivity and restructuring program aimed at generating annual pre-tax savings of $200 million to $300 million by 2028.

stocktwits.com2 min